Changing from NAFLD to MASLD: Similar prognosis of patients with HCC under atezolizumab/bevacizumab treatment between NAFLD and MASLD
Hiroyuki Suzuki, Shigeo Shimose, Hideki Iwamoto, Takashi Niizeki, Takumi Kawaguchi
Topics & Concepts
MedicineInternal medicineGastroenterologyOncologyLiver Disease Diagnosis and TreatmentDiet, Metabolism, and DiseaseHepatitis C virus research